Robyn Schlicher, Ph.D
Dr. Robyn Schlicher is a business development and marketing leader with a Ph.D. in Bioengineering. Her expertise lies in structuring complex business concepts and technical challenges, managing cross-functional teams, and teaching analytical processes. She is an entrepreneur with experience in global research/clinical projects. Dr. Schlicher excels in enterprise sales by combining science, engineering, medicine, strategic marketing, and business development.
Her skills include consulting for executives and investors, developing marketing collateral, delivering engaging presentations, building consensus across global teams, leading product pricing and positioning strategies, negotiating agreements, and managing pipelines using CRM tools. She is well-versed in CLIA laboratory practices, FDA auditable document creation, and navigating global markets for various industries. Additionally, she has a strong background in immuno-oncology, targeted therapies, and biomarker development.
Dr. Schlicher's educational background includes a Ph.D. in Bioengineering from Georgia Institute of Technology, a Master of Science in Chemical Engineering from the same institution, and a Bachelor of Science in Chemical Engineering from The University of Tulsa.
Throughout her career, Dr. Schlicher has held roles such as Director, Head of Commercialisation at The iQ Group Global, Scientific Advisory Board Member at Cell Constructs, Inc., and various positions in business development, sales, and consulting in biotechnology, oncology, and imaging companies.
She is a published technical writer with over 300 citations, skilled in developing partnerships, managing deals over $1M, and overseeing complex projects from conception to completion. Her diverse experience spans start-ups, large corporations, universities, healthcare systems, and government agencies.
Disclaimer: Dr. Robyn Schlicher's views expressed on social media are personal and not representative of The iQ Group Global or its affiliates.
